Clinical Trials Directory

Trials / Completed

CompletedNCT02082587

Toronto BNB Pilot Study

Pilot Study of the Toronto Brief Neurocognitive Battery (BNB)

Status
Completed
Phase
Study type
Observational
Enrollment
39 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

As treatments improve and patients live longer with cancer, even after it has spread to the brain, efforts to improve quality of life are growing. Neurocognitive function (thinking ability and memory) is an area of particular concern for patients with brain metastases (cancer that can spread to the brain). Although there are established tests to measure neurocognitive function, these require a face-to-face assessment and can take a long time to complete. As a result, efforts to use these tests to measure changes in neurocognitive function in patients following treatment for brain metastases have resulted in a large proportion of patients who do not return for follow-up. This has limited the ability to evaluate the impact of current treatments on neurocognitive function. This study aims to evaluate a shorter, telephone-based neurocognitive assessment tool, which would make it easier for patients to complete these tests in follow-up. If this new tool is found to reliably measure neurocognitive function, it could be used for future studies evaluating new interventions that prevent or treat neurocognitive deterioration following treatment of brain metastases. This is the first prospective study to evaluate the feasibility and reliability of a novel telephone-based brief neurocognitive assessment battery (Toronto BNB) compared with the same battery delivered face-to-face in this population. The investigators hypothesize that telephone administration of this brief neurocognitive battery will reliably evaluate neurocognitive function and improve patient ability to complete follow-up assessments.

Conditions

Timeline

Start date
2014-09-01
Primary completion
2017-02-02
Completion
2017-02-02
First posted
2014-03-10
Last updated
2017-02-08

Locations

3 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT02082587. Inclusion in this directory is not an endorsement.

Toronto BNB Pilot Study (NCT02082587) · Clinical Trials Directory